This document discusses the importance of clinical research on the effects of the fed vs. fast state on medication pharmacokinetics and pharmacodynamics. It provides examples of past research that have looked at how food intake can impact drug absorption, efficacy, and safety. The document also reviews FDA guidance on designing fed vs. fast clinical studies, including recommendations on subject selection, dosage, test meals, administration, sample collection, and data analysis. Examples of specific drugs that have been studied, such as omeprazole, pantoprazole, clopidogrel, cefalexin, and abacavir are also summarized.